PYPD 3.59 (+4.66%)
IL0011326795BiotechnologyBiotechnology

PolyPid (PYPD) Stock Highlights

3.59 | +4.66%
2024-10-21 05:46:47
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Companys proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.

Statistics

Range Today
3.59 3.59
Volume Today 900
Range 1 Year
2.95 9.2
Volume 1 Year 1.25M
Range 3 Year
2.95 257.1
Volume 3 Year 5.15M
Range 10 Year
2.95 583.5
Volume 10 Year 5.75M

Highlights

Market Capitalization 24.42M (micro)
Floating Shares 2.42M
Current Price 3.59
Price To Earnings -0.41
Price To Book 10.75
Earnings Per Share -8.76
Payout Ratio 0%

Performance

Latest +4.66%
1 Month +3.76%
3 Months -1.37%
6 Months -19.14%
1 Year -4.52%
3 Years -98.43%
5 Years -99.25%
10 Years -99.25%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.